中国医院用药评价与分析2024，Vol.24Issue(11)：1376-1380,5.DOI:10.14009/j.issn.1672-2124.2024.11.018
基于属性层次模型的伊伐布雷定药物利用评价标准的建立与应用
Establishment and Application of Evaluation Criteria for Drug Utilization Evaluation of Ivabradine Based on Attribute Hierarchy Model
摘要
Abstract
OBJECTIVE:To establish the drug utilization evaluation(DUE)criteria of ivabradine,and evaluate the rationality of clinical application of ivabradine by attribute hierarchy model(AHM).METHODS:Based on drug instructions of ivabradine,related guidelines or expert consensus,the DUE criteria of ivabradine was established,and the archived medical records of 83 cases with ivabradine application in the hospital from May 2022 to Apr.2024 were evaluated by AHM method.RESULTS:The top 3 irrational rates of ivabradine from high to low were improper administration routes in 60 cases(72.29%),improper selection of drugs in 41 cases(49.40%),improper usage and dosage in 29 cases(34.94%).Among the 83 medical records,14 cases(16.87%)had medical record score(MRS)≥90 points,39 cases(46.99%)had MRS from 70 to<90 points,23 cases(27.71%)had MRS from 60 to<70,and 7 cases(8.43%)had MRS<60 points.CONCLUSIONS:There are many irrational application of ivabradine in clinical application in the hospital,DUE criteria based on AHM method can intuitively quantify the evaluation results.关键词
伊伐布雷定/药物利用评价/属性层次模型/评价标准Key words
Ivabradine/Drug utilization evaluation/Attribute hierarchy model/Evaluation criteria分类
医药卫生引用本文复制引用
王栓,齐腊梅,黄灿..基于属性层次模型的伊伐布雷定药物利用评价标准的建立与应用[J].中国医院用药评价与分析,2024,24(11):1376-1380,5.基金项目
中华国际医学交流基金会临床药学专项基金项目(No.Z-2021-46-2101) （No.Z-2021-46-2101）
